Bad Genes, Good Drugs
Bad Genes, Good Drugs
Wondering what happened to all that knowledge we got from mapping the human genome?
Bad Genes, Good Drugs
Wondering what happened to all that knowledge we got from mapping the human genome?
New `greenhouses’ to promote biotechnology businesses
“With fanfare that extended beyond state boundaries into prime technological turf, Pennsylvania on Wednesday began channeling $100 million to three life-sciences “greenhouses” meant to cultivate biotechnology business in the state. “
Biotech industry in race for space
“The most critical issue facing those who create and test cutting-edge drugs is finding adequate space to manufacture them.”
Yali Friedman lives in Washington, DC and is author of Building Biotechnology and other books; founder of DrugPatentWatch; and chief editor of the Journal of Commercial Biotechnology.

Recent Comments